Org.nr 915 108 598 2023 → 2024 Year-over-year analysis

ABLY MEDICAL AS: årsregnskap 2024 vs 2023

Grew 34% on revenue, stronger earnings, fresh owner capital

approved 2025-06-20; registry 2025-07-07; journal 2025 638760

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2024 with 2023 for ABLY MEDICAL AS. Revenue 13.65m NOK → 18.34m NOK (+34.4%). Net result -6.21m NOK → -3.08m NOK. Equity 50.61m NOK → 87.92m NOK.

On the constructive side: revenue rose; operating result improved; net result improved.

Also worth watching: book investments changed; headcount (årsverk) changed. All figures are taken from the published annual accounts for ABLY MEDICAL AS.

Scorecard

Revenue
13.65m NOK 18.34m NOK
+34.4%
Operating result
-5.44m NOK -3.11m NOK
+42.8%
Net result
-6.21m NOK -3.08m NOK
+50.4%
Equity
50.61m NOK 87.92m NOK
+73.7%
Cash
426.6k NOK 474.6k NOK
+11.3%
Total assets
63.34m NOK 99.93m NOK
+57.8%

What improved

  • ↑

    Revenue rose

    Operating income / revenue moved from 13.65m NOK to 18.34m NOK (+34.4% YoY). Calculated

  • ↑

    Operating result improved

    Operating result -5.44m NOK → -3.11m NOK (op. margin -39.8% → -17.0%). Calculated

  • ↑

    Net result improved

    Net result -6.21m NOK → -3.08m NOK (net margin -45.5% → -16.8%). Calculated

  • ↑

    Equity strengthened

    Book equity 50.61m NOK → 87.92m NOK (equity ratio 79.9% → 88.0%). Calculated

  • ↑

    Cash rose

    Bank deposits 426.6k NOK → 474.6k NOK (+11.3% YoY). Calculated

Things to notice

  • ·

    Book investments changed

    Investment / intangible book value 1.80m NOK → 355.9k NOK. Reported fact

  • ·

    Headcount (årsverk) changed

    Reported FTEs 13.2 → 8.86. Reported fact